Embedded Files
1. Introduction
1-1 Introduction [R]
1-1 Introduction [R]
1-2 Identifying Assets for Impairment [R]
1-2 Identifying Assets for Impairment [R]
1-3 Q&A Premier Limited [R]
1-3 Q&A Premier Limited [R]
1-4 Q&A Entity Q(i) [O]
1-4 Q&A Entity Q(i) [O]
2. Measuring recoverable amount
2-1 Measuring Recoverable Amount [I]
2-1 Measuring Recoverable Amount [I]
Query: If both forced sale value and fair value are given then what will be used for calculating impairment? and....if we get compensation for faulty asset after a year, what will be it's treatment?
Response:Â
1. Forced sales value (FSV) is not fair value and it is not used in any of the IFRS as acceptable measurement basis. Therefore, you will use fair value for calculating "fair value less costs of disposal" while applying IAS 36 requirements.
2. Compensation from third parties for items of property, plant and equipment that were impaired, lost or given up shall be included in profit or loss when the compensation becomes receivable. [IAS 16 Para 65]
2-2 Q&A Sky - Line Limited [O]
2-2 Q&A Sky - Line Limited [O]
2-3 Q&A Naveed Limited [O]
2-3 Q&A Naveed Limited [O]
2-4 Q&A Hussain Associates Limited [O]
2-4 Q&A Hussain Associates Limited [O]
3. Recognition
3-1 Recognition  [I]
3-1 Recognition  [I]
Query: Sir Impairment loss and Reveluation loss different nhi hote Impairment has its own Standard IAS 36
Response: Impairment and revaluation are terms closely related to one another, with subtle differences. The calculation mechanism differs as in revaluation carrying amount is compared with fair value while in impairment carrying amount is compared with recoverable amount. However, same accounting entries method works for both and therefore these are often used interchangeably.
3-2 Q&A A Company [O]
3-2 Q&A A Company [O]
3-3 Q&A Entity Q(ii) [O]
3-3 Q&A Entity Q(ii) [O]
4. Comprehensive Examples
4-1 Q&A Zarmoney Limited (ICAP Autumn 2022) [I]
4-1 Q&A Zarmoney Limited (ICAP Autumn 2022) [I]
Query: Sir risk free interest 8% nae tha leana?
Response: IAS 36 Para 55:
The discount rate (rates) shall be a pre‑tax rate (rates) that reflect(s) current market assessments of:
(a) the time value of money; and
(b) the risks specific to the asset for which the future cash flow estimates have not been adjusted.
The same concept discussed in our video lecture: https://www.youtube.com/watch?v=JuxGWPaRPcg
Query: Sir depreciation and tax payments ko inflows mein add kyun kia hai? Depreciation and tax payments ko ignore karte hain ias 36 mein?? Sir plz explain
Response: Yes. Depreciation and tax must be ignored. However, question stated that these are INCLUDED. So in order to REVERSE them we have to "ADD BACK" these amounts.
4-2 Q&A Barbary Cement Limited (ICAP Autumn 2021) [I]
4-2 Q&A Barbary Cement Limited (ICAP Autumn 2021) [I]
4-3 Apricot Pakistan Limited (ICAP Autumn 2018) [I]
4-3 Apricot Pakistan Limited (ICAP Autumn 2018) [I]
Correction: It should be "Rs. million" instead of "Rs. 000" in working 1 Value in use.
4-4 Q&A Jazib Limited [I]
4-4 Q&A Jazib Limited [I]
4-5 Q&A Ghalib Limited [I]
4-5 Q&A Ghalib Limited [I]
4-6 Q&A Indus Pharma Limited (IPL) (ICAP Autumn 2020) [I]
4-6 Q&A Indus Pharma Limited (IPL) (ICAP Autumn 2020) [I]
Query: Sir we have returned our grant then why amount on which dep is to be reflected is 630 so far
Response: Rs. 630 million is amount without deduction of grant (so return of grant means still this would be the amount). Alternatively, try to understand whole time line of carrying amount of plant as follows:
Year 1: 630 - 280 grant = 350 - 50 Depreciation = 300
Year 2: 300 - 50 Depreciation = 250
Year 3: 250 - 50 Depreciation = 200
Year 4: 200 - 50 Depreciation = 150
Year 5: 150 + 280 repayment of grant - 160 Additional depreciation = 270 - 90* = 180
*90 calculated as 270 / 3 years remaining life or 630 / 7 years original life
4-7 Q&A Monday Limited (ICAP Autumn 2019) [R]
4-7 Q&A Monday Limited (ICAP Autumn 2019) [R]
4-8 Q&A Orchid Limited (ICAP Spring 2018) [X]
4-8 Q&A Orchid Limited (ICAP Spring 2018) [X]
4-9 Q&A Sumerian Limited (ICAP Spring 2023) [I]
4-9 Q&A Sumerian Limited (ICAP Spring 2023) [I]
4-10 Q&A ABA Limited [X]
4-10 Q&A ABA Limited [X]
5. Objective Based Q&A
5-1 MCQs 1 to 10 [O]
5-1 MCQs 1 to 10 [O]
5-2 MCQs 11 to 20 [O]
5-2 MCQs 11 to 20 [O]
5-3 MCQs 21 to 30 [O]
5-3 MCQs 21 to 30 [O]
5-4 MCQs 31 to 40 [O]
5-4 MCQs 31 to 40 [O]
Page updated
Google Sites
Report abuse